The Predictive Value of Baseline Target Lesion SYNTAX Score for No-Reflow during Urgent Percutaneous Coronary Intervention in Acute Myocardial Infarction
Table 1
Baseline patient characteristics.
All (n = 487)
Reflow (n = 435)
No-reflow (n = 52)
value
Age, yrs
58.14 ± 11.68
57.80 ± 11.43
60.96 ± 13.36
0.065
Male
384 (78.9%)
340 (78.2%)
44 (84.6%)
0.281
Body mass index, kg/m2
26.13 ± 3.20
26.08 ± 3.29
26.60 ± 2.35
0.155
Diabetes
135 (27.7%)
120 (27.6%)
15 (28.8%)
0.848
Hypertension
299 (61.4%)
265 (60.9%)
34 (65.4%)
0.532
Hyperlipidemia
293 (60.2%)
263 (60.5%)
30 (57.7%)
0.700
Smoking history
324 (66.5%)
289 (66.4%)
35 (67.3%)
0.900
Previous MI
64 (13.1%)
56 (12.9%)
8 (15.4%)
0.612
Previous PCI
100 (20.5%)
92 (21.1%)
8 (15.4%)
0.331
Previous stroke
61 (12.5%)
56 (12.9%)
5 (9.6%)
0.502
Peripheral vascular disease
29 (6.0%)
25 (5.7%)
4 (7.7%)
0.536
COPD
10 (2.1%)
10 (2.3%)
0 (0.0%)
0.610
Creatinine clearance (ml/min)
93.05 ± 26.55
93.45 ± 27.06
89.74 ± 21.85
0.342
Ejection fraction (%)
56.11 ± 7.63
56.75 ± 7.31
50.74 ± 8.11
<0.001
EF < 40% or HF
32 (6.6%)
22 (5.1%)
10 (19.2%)
0.001
STEMI
263 (54.0%)
221 (50.8%)
42 (80.8%)
<0.001
Hemoglobin (g/L)
141.66 ± 21.07
141.02 ± 20.98
148.78 ± 21.06
0.067
White blood cell count (109/L)
8.93 ± 3.12
8.86 ± 3.04
9.77 ± 3.88
0.146
Platelet count (109/L)
217.66 ± 69.28
218.62 ± 70.66
206.96 ± 51.18
0.403
hs-CRP (mg/L)
7.62 ± 5.27
7.62 ± 5.27
7.57 ± 5.46
0.972
Total cholesterol (mmol/L)
4.43 ± 1.07
4.46 ± 1.07
3.99 ± 0.80
0.153
LDL-C (mmol/L)
2.74 ± 0.90
2.74 ± 0.91
2.59 ± 0.65
0.562
HDL-C (mmol/L)
1.01 ± 0.29
1.01 ± 0.29
1.00 ± 0.21
0.952
Left main disease and/or 3-vessel disease
213 (43.7%)
186 (42.8%)
27 (51.9%)
0.208
Multivessel disease
354 (72.7%)
315 (72.4%)
39 (75.0%)
0.692
Baseline SYNTAX score
14.56 ± 8.04
14.03 ± 7.87
18.98 ± 8.21
<0.001
Note. All data are presented as n (%) or mean ± SD. COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; EF, ejection fraction; HDL-C, high-density lipoprotein cholesterol; HF, heart failure; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction.
